Related Experiment Video
Updated: Aug 28, 2025

07:29
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
19.7K
Phenomenological Approach to Cancer Cell Persistence
David A Kessler1, Herbert Levine2
1Department of Physics, Bar-Ilan University, Ramat-Gan 52900, Israel.
Physical Review Letters
|September 16, 2022
Summary
Cancer cells can survive targeted therapy by entering a dormant state. Quantitative genetics reveals that alternating drug treatments may not effectively eliminate these drug-tolerant persister cells.
Area of Science:
- Cancer Biology
- Quantitative Genetics
- Pharmacology
Background:
- Drug persistence is a key challenge in cancer therapy, where a subset of cancer cells survive treatment by entering a quiescent state.
- These persister cells can reactivate, leading to tumor recurrence and therapeutic resistance.
Purpose of the Study:
- To apply a quantitative genetics approach to understand the inheritance of drug persister probability in cancer cell populations.
- To interpret experimental data on cancer cell persister dynamics under drug exposure.
Main Methods:
- Utilized a quantitative genetics framework to model drug-exposed cancer cell populations.
- Analyzed experimental data on the inheritance of persister cell probability.
Main Results:
- The study's findings suggest that intermittent drug treatment (alternating drug exposure and removal) may not be an effective strategy for eradicating drug-tolerant persister cells.
- Inheritance of persister probability plays a significant role in the survival dynamics of cancer cells.
Conclusions:
- Alternating drug treatment and removal cycles may not be optimal for eliminating cancer cell persisters.
- Understanding the genetic basis of persister cell inheritance is crucial for developing effective cancer treatment strategies.
Related Concept Videos
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
What is Cancer?
11.0K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
11.0K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer
49.3K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
49.3K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K

